在患有心房动和阻塞性睡眠呼吸暂停的患者中进行心脏重塑

Tove Elizabeth Frances Hunt1,2,3,4, Gunn Marit Traaen5,2,6, Lars Aakerøy7,8

  • 1Department of Cardiology, Oslo universitetssykehus Hjerte- lunge- og karklinikken, Oslo, Norway Tovebetta@msn.com.

Open heart
|October 30, 2024
PubMed
概括

持续正气道压力 (CPAP) 在12个月后没有逆转阻塞性睡眠呼吸暂停 (OSA) 和心房动 (PAF) 的患者的左心房 (LA) 重塑. 需要进一步的研究来探索OSA患者的替代治疗方法.

相关概念视频

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
130
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
394
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
1